Lidocaine (Lignocaine) inhibits sodium channels involving complex voltage and using dependence[1]. Lidocaine decreases growth, migration and invasion of gastric carcinoma cells via up-regulating miR-145 expression and further inactivation of MEK/ERK and NF-kappaB signaling pathways. Lidocaine is an amide derivative and has potential for the research of ventricular arrhythmia[2].
Molekulargewicht:
234.34
Reinheit:
99.96
CAS Nummer:
[137-58-6]
Formel:
C14H22N2O
Target-Kategorie:
Apoptosis,ERK,MEK,NF-kappaB,Sodium Channel
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten